Navigation Links
E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries
Date:11/8/2007

broader innovations to come."

The quantitative results of the E.D.G.E. in Leadership study fill a significant knowledge gap in industry practices. "The HBA has always been committed to advancing women's careers, and the opportunity to work with Booz Allen Hamilton to document industry practices, as well as make recommendations for change, was a remarkable chance for our organization to further our own mission and form credible and lasting partnerships," says Cathy Kerzner, HBA President. "We look forward to the feedback we receive on the publication of these results, and we recognize the value of tracking progress over time. We are planning follow-up studies to further examine the impact of the study recommendations."

The effects of the study findings are anticipated to be wide-ranging and global. Florence Manger, President Elect of the HBA Europe Affiliate says: "I am very pleased at the publication of the E.D.G.E. in Leadership study, which provides first-of-its-kind insights into the advancement of women in the EU and the US. Armed with the results, we can better understand the dynamics on both continents and identify similarities and differences. I'm confident that women from across Europe will read this long-awaited study with great interest, and will do all they can to encourage their company's senior leadership to implement its recommendations."

Methodology

Eighty-two senior executives from 19 of the top 50 life sciences companies in the US and Europe participated in in-depth interviews, and 237 mid-level managers responded to a comprehensive survey. Twelve companies provided comprehensive staffing and program data from HR databases.

Sponsorships

The HBA E.D.G.E in Leadership study was funded by ten sponsors and nine contributors. Sponsors included Booz Allen Hamilton, Novartis, sanofi-aventis, Wyeth, Abbott Laboratories, AstraZeneca Pharmaceuticals LP, Celgene Corporation, Ernst & Young LLP, Johnson & Johnson, and Merck &
'/>"/>

SOURCE HBA Europe
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Yakima Health Care Leader Tapped for Leadership Post at National Association
2. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
3. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
4. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
5. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
6. Blue Care Network of Michigan Earns National Leadership Award for Chronic Disease Management
7. Schooner Healthcare Services, LLC Announces New Leadership Team
8. National Quality Forum Announces New Member Councils Leadership
9. Expansion and Growth Spur INSPIRIS Executive Leadership Promotions
10. Inter-American Leadership Award Bestowed Upon Chilean Chronic Disease Expert
11. amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Top 10 Best SEO Hosting, a ... GoDaddy and Bluehost are among the best web ... most recommended suppliers for webmasters from the USA, ... quality Linux hosting (including VPS and cloud hosting). ... many top hosting companies that started thinking Green. ...
(Date:9/19/2014)... Ticket Down has slashed ticket prices ... Tour. This popular ticket reseller is offering their customer ... , Ariana Grande 2015 Honeymoon Tour Dates: , Feb. 25, ... 2015: Milwaukee, WI (BMO Harris Bradley Center) , March 01, ... 2015: Chicago, IL (Allstate Arena) , March 05, 2015: Cleveland, ...
(Date:9/19/2014)... TORONTO, Sept. 19, 2014 York University researchers ... movement can help to detect heightened risk for ... there are any telltale behavioural signs of dementia., ... candidate Kara Hawkins who led the study asked ... and cognitive-motor tasks, on dual screen laptop computers. ...
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... over the five years to 2014. Industry operators were ... time during the period, as well as establish distribution ... is due in large part to its novelty; energy ... Nevertheless, in that time, industry operators have been able ...
(Date:9/19/2014)... California (PRWEB) September 19, 2014 ... by technological advancements, surgical techniques, and immunosuppressant drugs ... preferred treatment for several chronic diseases related to ... in organ and tissue transplantation have phenomenally revolutionized ... Organ transplant today represents a pivotal medical ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Announces Great Linux Web Hosting Suppliers In 2014 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 4Health News:Simple test can help detect Alzheimer's before dementia signs show: York U study 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 4
... president and founder of Allergy & Asthma Network Mothers ... patient access to all forms of 12-hour bronchodilators at ... Drug Safety and Risk Management Advisory Committee and Pediatric ... in Rockville, MD. , , ...
... provider of hair removal information and consultation scheduling on the ... for guests to locate and learn about consumer-rated laser clinics ... In recent weeks, Hair Removal Forum,s "Doctor Finder" function has ... in a number of unique ways. On the main doc ...
... 11 Based on its recent,analysis of ... recognizes,SourceOne Global Partners with the 2008 United ... methodically readying Cholesstrinol(TM) (a platform for,its multiple ... for,the marketplace. From establishing conclusive scientific evidence ...
... sophisticated gas analyzer that,measures carbon dioxide (CO2) under pressure ... CO2 dilutes explosive ... sterilizers and research laboratories. (EtO is both,toxic and extremely ... of intermolecular energy transfer between EtO and CO2 (and,nitrogen, ...
... professionals to use their clinical judgment to choose what is best ... , ST. PETERSBURG, Fla., Dec. 11 ... NYSE: SNN ) is pleased to announce the introduction ... The new dressing kits will be launched in the market ...
... & Gamble,Company (NYSE: PG ) is holding ... at 8:30 a.m. Eastern Time. Chairman of the ... executive management team will,provide a review of the company,s ... Mr. Lafley will ...
Cached Medicine News:Health News:AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators 2Health News:Hair Removal Forum Unveils New 'Doctor Finder' Interface 2Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 2Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 3Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 4Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 5Health News:New Analyzer Measures CO2 at High Pressures 2Health News:Introducing the Smith & Nephew Foam Dressing Kit 2Health News:Introducing the Smith & Nephew Foam Dressing Kit 3Health News:Introducing the Smith & Nephew Foam Dressing Kit 4Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 3Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 4
(Date:9/19/2014)... -- CytRx Corporation (Nasdaq: CYTR ), a biopharmaceutical ... that David J. Haen , Vice President, Business ... Biotech Industry Conference on Friday, September 26 th at ... at the Millennium Broadway Hotel in New ... archived webcast of the presentation will be available on ...
(Date:9/18/2014)... , Sept. 18, 2014  Low T Center ... meeting in Hyattsville, Maryland ... assess the proper patient population for testosterone therapy ... risk associated with TRT. Examining recent claims from studies ... that "available epidemiological studies do not provide convincing ...
(Date:9/18/2014)...   MacPractice,s MacPractice MD MU version 5.0 ... which designates that the software is capable of supporting ... 2 Meaningful Use measures required to qualify for funding ... MD MU version 5.0 was certified on June 6, ... the National Coordinator-Authorized Certification Body (ONC-ACB) and is compliant ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... Sanofi-aventis (EURONEXT: SAN and NYSE: ... today announced that The New England Journal ... II data for the investigational drug iniparib* (BSI-201) ... triple negative breast cancer (mTNBC) when iniparib was ...
... 2011 MiMedx Group, Inc.  (OTC Bulletin ... and marketer of patent protected biomaterial-based products, announced today ... leader in the development of tissue processing techniques for ... amnion membranes. The deal was originally announced on December ...
Cached Medicine Technology:Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 2Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 3Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 4Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 5Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 6MiMedx Completes Acquisition of Surgical Biologics 2MiMedx Completes Acquisition of Surgical Biologics 3MiMedx Completes Acquisition of Surgical Biologics 4
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
Medicine Products: